Trials / Sponsors / Alladapt Immunotherapeutics, Inc.
Alladapt Immunotherapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Open-label Extension Study of ADP101 Food Allergy | Phase 1 / Phase 2 | 2022-03-14 |
| Completed | ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Food Allergy | Phase 1 / Phase 2 | 2021-04-20 |